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Abstract
Primary pulmonary non-Hodgkin’s lymphoma is a very rare neoplasm. It is most frequently
represented by the mucosa-associated lymphoid tissue type. We describe a case of a 67-year-old
woman who presented with fatigue, mild dyspnea, and consolidation on chest radiograph. The
diagnosis of non-Hodgkin’s lymphoma was established by transbronchial biopsy, and chemotherapy
was then started. The patient was treated with 6 cycles of chemotherapy. She had good response to
therapy and no progression of the disease was observed during a 4-year follow-up period. The
clinical, radiological and histopathological features are described. This entity has an indolent course,
good response to therapy and favorable prognosis. However, despite being an incidental radiological
finding in a third of cases, this disease remains highly underdiagnosed.
Introduction
Lymphomas of the lung can be classified into four
categories of disease: primary pulmonary involvement,
recurrent or secondary lymphoma of the lung, lymphoma
in patients with post-transplantation lymphoproliferative
disorders, and AIDS-related lymphoma [1-4].
Primary pulmonary lymphoma (PPL) is a rare entity,
accounting for only 0, 5-1% of all pulmonary malignan-
cies and less than 1% of all lymphomas. It is defined as a
clonal lymphoid proliferation affecting one or both lungs
(parenchyma and/or bronchi) in a patient with no
evidence of mediastinal adenopathy, no detectable extra-
pulmonary involvement by clinical staging work-up, no
past history of lymphoma, and no evidence of extrathor-
acic disease up to 3 months [1,5,6]. PPL is usually a non-
Hodgkin lymphoma (NHL), and according to the World
Health Organization’s classification system, it can be
divided into two types:mucosa-associated lymphoid tissue
(MALT) and non-MALT. The former is represented by the
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low-grade extranodal marginal zone B-cell lymphoma
(58%-87%), while the latter consists of diffuse large B-cell
or high-grade lymphoma (11%-19%) and anaplastic large
cell lymphoma [6-8]. MALT is a term that describes the
specialized lymphoid tissue involved in mucosal defense,
which is located beneath the epithelium [1,9].
When located in the lung, this lymphoma appears to arise
from preexistent resident bronchus-associated lymphoid
tissue (BALT) and is thought to be acquired as a result of
chronic antigenic stimulation such as smoking, autoim-
mune diseases, or infections [1,6,7,9-11]. In fact, before
the development of more accurate immunohistochemical
techniques and molecular biology-based method, most
cases were classified as pseudo-lymphomas, a benign
inflammatory lymphocytic infiltrate [1,7].
Primary pulmonary MALT lymphoma often occurs in the
fifth to seventh decade of life; subjects under the age of
30 years are rarely affected. The majority of studies reports
that the two genders are equally affected [1,7], although a
female predominance has been suggested [1]. They
infiltrate the pulmonary interstitium, often massively,
and may form nodular aggregates and extend into the air
spaces [10]. Most of the patients (50%) are asymptomatic
and the lesion is discovered incidentally on chest radio-
graph, while 46% have respiratory symptoms and non-
specific pulmonary complaints. In a minority of patients,
constitutional features like weight loss, fever or malaise
have been reported at presentation [5,6,10].
Pulmonary lymphoma can present with different radio-
logical manifestations, including single or multiple
nodules, masses, infiltrates and consolidations. This
suggests that any radiological abnormality of the lung
parenchyma may be a lymphoma [6]. Several treatment
options are available, including tumor resection, radio-
therapy, surgery with adjuvant chemotherapy or chemo-
therapy alone. The treatment remains controversial but the
prognosis is excellent [5-7,9].
Case presentation
A 67-year-old Afro-American Brazilian woman was
admitted with a 4-month history of fatigue and progres-
sive dyspnea on exertion. She was diagnosed with hepatitis
C three months earlier, without treatment. She denied
fever, weight loss, smoking and drug or alcohol abuse.
Physical examination revealed an ill-looking, emaciated
woman, with a blood pressure of 120/80 mmHg, a heart
rate of 100 bpm, and a respiratory rate of 27 breaths/min.
In the assessment of the respiratory system, there were
signs of airspace consolidation in the upper third of the
left hemithorax. Inspiratory crackles were heard in
the lower third of the hemithorax. The remainder of the
examination was normal.
Laboratory evaluation revealed a red blood cell (RBC)
count of 5, 13 million/mm³, hemoglobin level of
11.8 g/dl, hematocrit of 35.9%, and platelet count of
117,000/mm³. The WBC count was 3,600/mm³ (basophils
1%; eosinophils 3%; band neutrophils 0%; segmented
neutrophils 56%; lymphocytes 34%; monocytes 6%);
MCV 73 μm³; MCHC 32.7 g/dl; ESR 53 mm/h. Absolute
and relative reticulocyte count were 320,450/mm³ and
6.5%, respectively. Hematoscopy showed anisocytosis,
microcytosis and hypochromia. Liver function tests were
normal, and serology for HIV was negative.
Chest radiograph revealed consolidations in the upper
lobe of the left lung and in the lower lobe of the right lung
(Figure 1). High-resolution computed tomography (CT)
showed a consolidation with air bronchograms in the
apicoposterior segment of the left upper lobe and small
areas of consolidation in the right lower lobe. No
lymphadenopathy was detected (Figure 2).
She had a negative tuberculin skin test reaction, and six
sputum samples were negative for acid-fast bacilli.
Cultures for mycobacteria and fungi were also negative.
Bronchoscopy showed no abnormalities, and the cultures
of the bronchoalveolar lavage fluid were negative for
tuberculosis, fungi and other microorganisms. Transbron-
chial biopsy revealed infiltration of atypical lymphoid
B cells. Immunohistochemically, the lung tumor cells
Figure 1. Chest X-ray shows a large consolidation with air
bronchograms in the left lung, and a small area of
consolidation in the lower region of the right lung.
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expressed immunoreactivity for anti-CD20, oncoprotein,
Bcl-2, kappa light chain of immunoglobulin and cell
proliferation antigen Ki-67 (<10%). Anti-cytokeratin pan
antibody revealed areas of epithelial injury. Based on these
findings, the diagnosis of low-grade B-cell non-Hodgkin’s
lymphoma (MALT lymphoma) was made.
Additionally, a bone marrow biopsy was performed and
showed no neoplastic infiltration. Upper gastrointestinal
endoscopy did not find areas of metaplasia, and abdom-
inal CT was normal. The absence of lymphadenopathy or
other signs of extrathoracic disease defined the lymphoma
as primary and with exclusive pulmonary involvement.
She received six cycles of chemotherapy with
cyclophosphamide, vincristine and prednisone (Oncovir)
over a three-month period, with complete remission of the
symptoms. The patient underwent biannual clinical and
radiological follow-up, and during the next four years, no
changes were detected. There was no additional treatment
performed, and the disease was considered in remission.
Discussion
Due to its rarity, relatively little is known about the natural
history of BALT lymphomas in terms of local infiltration
and dissemination. However, it is characteristic that the
lesions remain restricted to the lungs for long periods of
time before dissemination. The interval between the first
clinical or radiological manifestation and diagnosis ranges
Figure 2. High-resolution CT scans with parenchymal (A and B) and mediastinal (C and D) window settings demonstrate a
consolidation with air bronchogram in the apicoposterior segment of the left upper lobe, and in the superior segment of the left
lower lobe.
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from 5 months to 8 years, which reflects the indolent
course of this disease [1,7].
When present, symptoms such as cough, mild dyspnea,
chest pain and occasionally hemoptysis, are nonspecific.
Pulmonary auscultation reveals crackles in 20% of cases
[1]. Our patient had fatigue and progressive dyspnea on
exertion as unique symptoms, associated with nonspe-
cific laboratory abnormalities and signs of lung
consolidation on physical examination and in chest
radiograph.
The most common radiological findings of PPL are uni- or
bilateral pulmonary infiltrates or nodules, in a peribronch-
ovascular distribution [2-4,6]. Usually the appearance is an
area of localized alveolar opacity with poorly defined
margins, which is associated in nearly 50% of cases with air
bronchograms [1,10]. CT, which is more sensitive, usually
demonstrates consolidations, areas of ground-glass
opacities and peribronchovascular thickening. These
lesions are usually bilateral (60-70%) and multiple
(70-77%) [3,10,11].
The criteria for diagnosis of primary pulmonary lym-
phoma are not clearly established and include histology,
immunohistochemistry and molecular biology findings,
and the natural history of various specific types of
lymphomas. An extensive staging workup, including
upper and lower gastrointestinal endoscopies and bone
marrow biopsies is also recommended [5].
Bronchial endoscopy usually shows a normal macroscopic
aspect, although abnormalities ranging from mucosal
inflammation to bronchial stenosis can be observed [1].
BAL fluid may demonstrate an increased cellularity with a
predominant lymphocytosis, and flow cytometry analysis
can aid in establishing the diagnosis. A histological
diagnosis can be obtained by bronchial or transbronchial
biopsy or by transthoracic fine-needle aspiration [8].
This diagnostic yield is higher when it targets visible
endobronchial lesions or radiographic abnormalities;
when it does not, a surgical biopsy is essential for
establishing the diagnosis in some cases [5].
Treatment provides extremely low mortality rates, reach-
ing a 5-year survival rate of 100% [9]. Although
therapeutic consensus has not been clearly established,
in asymptomatic cases with indolent clinical course, initial
observation seems to be a reasonable option for some
studies. However, other studies show that BALT lympho-
mas can occasionally progress more rapidly to massive
lung infiltration, indicating that diagnostic efforts and
treatment should not be delayed [6,7]. In most studies,
surgical resection, either alone or in combination with
chemotherapy, has been the mainstay of therapy. Despite
their indolent behavior and excellent prognosis, the
prognostic factors have not been well defined [5] and
the disease tends to relapse frequently. Its progression has
been associated with large-cell transformation of MALT
lymphomas [7].
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